Regulation - Research, Amgen

Filter

Current filters:

ResearchAmgen

Popular Filters

FDA suspends pediatric trial of Amgen's Sensipar after patient death

27-02-2013

The US Food and Drug Administration revealed yesterday that it has stopped all pediatric clinical trials…

AmgenBiotechnologyRegulationResearchSensipar

Amgen’s Prolia increases bone mineral density over eight; new indications approved

20-09-2011

The world’s largest biotechnology firm, USA-based Amgen (Nasdaq: AMGN) says that new long-term data…

AmgenAnti-Arthritics/RheumaticsBiotechnologyGlaxoSmithKlinePharmaceuticalProliaRegulationResearchXgeva

Company Spotlight

ImmunoGen

ImmunoGen

Back to top